Literature DB >> 30875453

Mortality of patients with haemophilia in Brazil: First report.

Leticia Lemos Jardim1,2, Johanna G van der Bom2,3, Camila Caram-Deelder2,3, Samantha Claudia Gouw3, Mariangela Leal Cherchiglia1, Suely Meireles Rezende1.   

Abstract

INTRODUCTION: Brazil has the fourth largest world population of patients with haemophilia. However, mortality rates in this population are unknown. AIM: To analyse mortality and its causes in Brazilian patients with haemophilia from 2000 to 2014.
METHODS: The number of deceased patients with haemophilia and causes of death were obtained from the Brazilian National Mortality Information System (SIM), according to the 10th International Classification of Diseases (ICD-10). Standardized mortality ratios (SMR) were calculated to estimate the rate of overall death of patients with haemophilia relative to that of the Brazilian general male population.
RESULTS: A total of 784 deaths were identified in the period of 15 years. Mortality of patients with haemophilia was 13% higher when compared with the general male population (SMR 1.13, 95% CI: 1.01-1.16). Haemorrhage was the main cause of death (n = 254; 32.4%) of which 137 (54%) was intracranial haemorrhage. The total number of deaths due to HIV decreased over the years, and an increase in deaths due to cancer and cardiovascular disease was observed. A total of 129 deaths (16.5%) were related to hepatitis infection, of whom, 109 (86.5%) patients also presented with cirrhosis and hepatocellular carcinoma or other liver diseases.
CONCLUSION: Mortality rate of Brazilian patients with haemophilia decreased over the evaluated period. Intracranial haemorrhage is still an important cause of death in these patients, which requires major effort for prevention. Death due to age-related cardiovascular disease and cancer has increased over the years, following the same tendency observed in developed countries.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Brazil; epidemiology; factor VIII; haemophilia; mortality; standardized mortality ratios

Mesh:

Year:  2019        PMID: 30875453     DOI: 10.1111/hae.13730

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  10 in total

1.  Building the National Program of Inherited Bleeding Disorders in Brazil.

Authors:  Suely M Rezende; Leticia L Jardim; Vera Lúcia Magalhães; Helder Teixeira Melo; João Paulo B Araujo; Guilherme Genovez
Journal:  Blood Adv       Date:  2019-12-06

2.  Factors Associated with Compliance with the Treatment Protocol and Mortality in Adults with Hemophilia.

Authors:  Beatriz Mac Dowell Soares; Luiz Alberto Simeoni; Karlo Jozefo Quadros de Almeida; Jaqueline Lima de Souza; Aline Mizusaki Imoto; Melina Swain Braverman; Lucas Barbosa Bezerra; Alexandre Jorge Teixeira Ribeiro; Ana Maria Costa; Fábio Ferreira Amorim
Journal:  Patient Prefer Adherence       Date:  2020-11-20       Impact factor: 2.711

Review 3.  Mortality in congenital hemophilia A - a systematic literature review.

Authors:  Charles R M Hay; Francis Nissen; Steven W Pipe
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

4.  Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database.

Authors:  Steven W Pipe; Rebecca Kruse-Jarres; Johnny N Mahlangu; Glenn F Pierce; Flora Peyvandi; Peter Kuebler; Christian De Ford; Fabián Sanabria; Richard H Ko; Tiffany Chang; Charles R M Hay
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

5.  Application of a hemophilia mortality framework to the Emicizumab Global Safety Database.

Authors:  Flora Peyvandi; Johnny N Mahlangu; Steven W Pipe; Charles R M Hay; Glenn F Pierce; Peter Kuebler; Rebecca Kruse-Jarres; Midori Shima
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

6.  Clinico-epidemiological and sociodemographic profile of patients with hemophilia in the Brazilian Amazon: High prevalence of hepatitis C infection and its possible corrrelation with inhibitor development.

Authors:  Enzo Miranda Santos; Jean de Melo Silva; Anderson Nogueira Barbosa; Gemilson Soares Pontes
Journal:  Front Public Health       Date:  2022-09-08

Review 7.  Cardiovascular disease in hereditary haemophilia: The challenges of longevity.

Authors:  Susan Shapiro; Gary Benson; Gillian Evans; Catherine Harrison; Sarah Mangles; Mike Makris
Journal:  Br J Haematol       Date:  2022-02-21       Impact factor: 8.615

8.  Hemophilia management: Huge impact of a tiny difference.

Authors:  Fabienne Kloosterman; Anne-Fleur Zwagemaker; Amal Abdi; Samantha Gouw; Giancarlo Castaman; Karin Fijnvandraat
Journal:  Res Pract Thromb Haemost       Date:  2020-02-28

Review 9.  Practical Recommendations for Treatment of Dental Patients with Congenital Bleeding Disorders during the Covid-19 Pandemic: A Narrative Review.

Authors:  Sylwia Czajkowska; Joanna Rupa-Matysek; Lidia Gil; Anna Surdacka
Journal:  Int J Environ Res Public Health       Date:  2020-10-03       Impact factor: 3.390

10.  Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001-2018.

Authors:  Shermarke Hassan; Rory C Monahan; Evelien P Mauser-Bunschoten; Lize F D van Vulpen; Jeroen Eikenboom; Erik A M Beckers; Louise Hooimeijer; Paula F Ypma; Laurens Nieuwenhuizen; Michiel Coppens; Saskia E M Schols; Frank W G Leebeek; Cees Smit; Mariëtte H Driessens; Saskia le Cessie; Erna C van Balen; Frits R Rosendaal; Johanna G van der Bom; Samantha C Gouw
Journal:  J Thromb Haemost       Date:  2020-12-18       Impact factor: 5.824

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.